[go: up one dir, main page]

SE8900835L - Foerbaettringar i samband med organiska foereningar - Google Patents

Foerbaettringar i samband med organiska foereningar

Info

Publication number
SE8900835L
SE8900835L SE8900835A SE8900835A SE8900835L SE 8900835 L SE8900835 L SE 8900835L SE 8900835 A SE8900835 A SE 8900835A SE 8900835 A SE8900835 A SE 8900835A SE 8900835 L SE8900835 L SE 8900835L
Authority
SE
Sweden
Prior art keywords
societies
organic
connection
nucleobase
sources
Prior art date
Application number
SE8900835A
Other languages
Unknown language ( )
English (en)
Other versions
SE8900835D0 (sv
Inventor
F B Rudolph
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8900835D0 publication Critical patent/SE8900835D0/sv
Publication of SE8900835L publication Critical patent/SE8900835L/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8900835A 1988-03-11 1989-03-09 Foerbaettringar i samband med organiska foereningar SE8900835L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16686688A 1988-03-11 1988-03-11

Publications (2)

Publication Number Publication Date
SE8900835D0 SE8900835D0 (sv) 1989-03-09
SE8900835L true SE8900835L (sv) 1989-09-12

Family

ID=22604997

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900835A SE8900835L (sv) 1988-03-11 1989-03-09 Foerbaettringar i samband med organiska foereningar

Country Status (9)

Country Link
JP (1) JPH01279835A (sv)
BE (1) BE1002937A5 (sv)
CH (1) CH681203A5 (sv)
DE (1) DE3907842A1 (sv)
FR (1) FR2628320A1 (sv)
GB (1) GB2216416B (sv)
IT (1) IT1232819B (sv)
NL (1) NL8900581A (sv)
SE (1) SE8900835L (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2529605B2 (ja) * 1989-10-23 1996-08-28 株式会社大塚製薬工場 免疫賦活剤
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US5700590A (en) * 1994-01-10 1997-12-23 Abbott Laboratories Nutritional formula with ribo-nucleotides
US5492899A (en) * 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US5488039A (en) * 1994-01-10 1996-01-30 Abbott Laboratories Method for the production of an enteral formula containing ribo-nucleotides
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20030026782A1 (en) 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US6706691B1 (en) 1998-07-15 2004-03-16 Board Of Regents, The University Of Texas System Immunosupportive drug sparing diet
ES2219182B1 (es) * 2003-05-12 2005-10-01 Jose Luis Concellon Martinez Procedimiento para compensar el efecto negativo en la salud de alimentos que contienen azucar refinado.

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS385291B1 (sv) * 1960-09-07 1963-05-07
US3231385A (en) * 1960-12-29 1966-01-25 Takeda Chemical Industries Ltd Dairy products
IL29066A (en) * 1966-12-23 1972-11-28 Merck & Co Inc Pharmaceutical preparations containing multi-chain poly-nucleotides to encourage interferon production in humans, animals or cell cultures
DE1617545C2 (de) * 1967-06-19 1983-11-03 Diether Prof. Dr. Bern Jachertz Verwendung von informatorischer Ribonucleinsäure als Vaccine
GB1254744A (en) * 1969-06-19 1971-11-24 Beecham Group Ltd Antiviral ribonucleic acid substance
DE1941942A1 (de) * 1969-08-18 1971-03-04 Sylven Bengt Prof Dr Neues pharmazeutisches Mittel
IT945910B (it) * 1971-04-08 1973-05-10 Erra C Spa Prodotto dietetico impiegabile quale intergratore dell alimenta zione umana con particolare riferi mento all infanzia agli stati di convalescenza di gravidanza d allat tamento e dell eta senile e procedi mento per la sua fabbricazione
US3914450A (en) * 1973-04-09 1975-10-21 Anheuser Busch Concentrated extract of yeast and processes of making same
GB1363398A (en) * 1973-03-29 1974-08-14 Yamasa Shoyu Kk Uridine-5.-monophosphate compositions
FR2353293A1 (fr) * 1976-06-03 1977-12-30 Beljanski Mirko Polyribonucleotides ayant une activite dans la genese des leucocytes et des plaquettes sanguines
FR2374911A1 (fr) * 1976-12-21 1978-07-21 Fabre Sa Pierre Adjuvants d'immunite non specifique
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
DE3380342D1 (en) * 1982-10-26 1989-09-14 Cta Finanz Ag Device and process for optimising the tissue mass of organs within the genetic fluctuation range in humans and animals
US4643992A (en) * 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
JPS59219235A (ja) * 1983-05-30 1984-12-10 Mitsui Toatsu Chem Inc 消化性潰瘍用剤
JPS608307A (ja) * 1983-06-28 1985-01-17 Ube Ind Ltd 補強ポリブタジエンの製造法
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
EP0196530A3 (de) * 1985-03-26 1989-03-22 CTA Finanz AG Mittel und Verfahren zur Beschleunigung des Wachstums, zur Optimierung der Fruchtbarkeit und zur Stimulierung des Immunsystems bei Mensch und Tier
JPH0669953B2 (ja) * 1985-08-16 1994-09-07 日産化学工業株式会社 脳脊髄系神経栄養剤

Also Published As

Publication number Publication date
GB8905179D0 (en) 1989-04-19
CH681203A5 (sv) 1993-02-15
SE8900835D0 (sv) 1989-03-09
IT8947733A0 (it) 1989-03-10
NL8900581A (nl) 1989-10-02
BE1002937A5 (fr) 1991-09-03
JPH01279835A (ja) 1989-11-10
GB2216416A (en) 1989-10-11
IT1232819B (it) 1992-03-05
GB2216416B (en) 1992-06-24
FR2628320A1 (fr) 1989-09-15
DE3907842A1 (de) 1989-09-21

Similar Documents

Publication Publication Date Title
DE68907483D1 (de) Vitamin d analoge.
IT1225701B (it) Poltrona per abbronzatura
DE3750772D1 (de) Zigarettenähnlicher Rauchartikel.
MX9204229A (es) Trifluorometilbencilfosfonatos utiles en el tratamiento de osteoporosis.
DE3870928D1 (de) Mit sauerstoff angereicherte verbrennung.
DE3872732D1 (de) Elektrolumineszente vorrichtung mit veraenderter lumineszenter duennschichtzone.
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
DK10389D0 (da) Fremgangsmaade til stimulering af haarvaekst
DK289285D0 (da) Thymopentin analoge
MX17877A (es) Composiciones antimalaria y metodos de tratamiento que utilizan quinidina, artemisinina y sus derivados.
SE8900835L (sv) Foerbaettringar i samband med organiska foereningar
DE3850134D1 (de) Härtbare und Aufschäumbare Polysiloxanzusammensetzung.
DK80588A (da) Fjerkrae-foder, fodringsmetode og fremgangsmaade til forbedring af fordoejeligheden af fjerkrae-foder
DE3785107D1 (de) Prepreg und dessen komposit.
ES2058343T3 (es) Piridinas disubstituidas.
FI894097A (fi) Piperazindioner med psykotropisk verkan.
IT1226386B (it) Procedimento di preparazione di morniflumato e analoghi.
DE3886744D1 (de) Spannungsquellen.
DK449986D0 (da) 12- og 13-substituerede ergolinderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse
NZ502862A (en) Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
ZA891242B (en) 24r-scymnol,and preparation and use thereof
ES551053A0 (es) Perfeccionamientos en el metodo de tratamiento de simil-cuero y cuero
CA2297984A1 (en) Ratite extracts as therapeutic agents
DK0528928T3 (da) Interleukin-4 bindingsprotein-gamma

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8900835-3

Effective date: 19940214